Whitepaper: FDA 483s and Non-compliance in Pharma

FDA 483 whitepaper download icon Fill in the form below to download our white paper on FDA 483s and non-compliance in the pharmaceutical industry.

The 483 form details improvements, or corrections, to remain compliant (and therefore operational). Not responding completely to the observations can have costly consequences.

Download this whitepaper to learn more about:

> What a 483 is, and why they are an essential tool for best practice compliance and quality management

> The consequences of non-compliance in drug production and QC, and how a company must respond to a 483 or product recall

> The contribution of compliant water purification systems to the success of drug production and QC



YES I'd like to receive updates from ELGA LabWater & Approved Partners based on my details

At ELGA LabWater, we have exciting offers and news about our lab water purification products that we hope you’d like to hear about. We will use your information to predict what you might be interested in. We will treat your data with respect and you can find the details in our Privacy Policy here.

ELGA Labwater works with a network of Approved Partners. In order to answer your questions or enquiries, we may pass your contact details to an Approved Partner, who may contact you directly. You can find a list of our Approved Business Partners here.

If you would like to receive updates from ELGA and our Approved partners please tick the box above: